Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human Platelets.

Publication Date

6-2019

DOI

10.1017/cts.2019.382

Publication Title

Journal of clinical and translational science

Share

COinS